How better protocol design can reduce white space in clinical development
White space is a key contributor to clinical trial delays, and smarter approaches to protocol design could help keep it at bay.
In Association With Fortrea
The CRO fueled by agility Together exceptional is possible
What causes white space in early-stage drug development?
Productivity hurdles: Why identifying and rectifying site-specific challenges is key to improving clinical trials
A quick guide to site selection (and why experience isn’t everything)
How collaborating with sites underpins faster study start-ups
Getting the balance right: The evolving role of AI in patient recruitment and trial delivery
Outsourcing trends in biopharma: What emerging biotechs need from their CROs
Six challenges facing emerging biotechs and how to solve them
